The development of highly effective biologics was preceded by research efforts over several decades. Advances in immunopathogenetic and molecular genetic analyses contributed significantly to the generation of these innovative system therapeutics. The Guenter Goerz Memorial Lecture of this year’s annual meeting of the Working Group for Dermatological Research was dedicated to this topic and spanned from milestones of psoriasis research to the biologics available today.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Post-COVID
Complaints from a neurological point of view
- Obstructive sleep apnea syndrome
Fitness to drive with OSAS
- Smoking cessation
On the way to better health – alternative nicotine products in view
- Age-related cognitive impairments
Ginkgo biloba extracts bring benefits
- Casuistry
SLE with kidney damage does not always have to be lupus nephritis
- Viral hepatitis
Hepatitis ABC(EN): Prophylaxis and treatment – an update
- Type 2 diabetes: reduction of microvascular and macrovascular risks
The extensive toolbox has a lot to offer
- Practice Management